Prevail Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PRVL and buy or sell other stocks, ETFs, and their options commission-free!

About PRVL

Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. 

CEO
Franz F. Hefti, PhD
CEOFranz F. Hefti, PhD
Employees
—
Employees—
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2017
Founded2017
Employees
—
Employees—

PRVL Key Statistics

Market cap
787.70M
Market cap787.70M
Price-Earnings ratio
-10.03
Price-Earnings ratio-10.03
Dividend yield
—
Dividend yield—
Average volume
1.19M
Average volume1.19M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$23.35
52 Week high$23.35
52 Week low
$9.02
52 Week low$9.02

People also own

Based on the portfolios of people who own PRVL. This list is generated using Robinhood data, and it’s not a recommendation.
Moderna
Plug Power
Pfizer
Aphria
FuelCell Energy
Virgin Galactic Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.